Abstract | INTRODUCTION: METHODS: The following cell lines were used for in vitro binding and PET experiments: the epidermoid carcinoma cell line A-431 ( erlotinib-sensitive, wild-type EGFR) and the three NSCLC cell lines HCC827 (erlotinib-sensitive, delE746-A750), HCC827EPR ( erlotinib-resistant, delE746-A750 and T790M) and HCC827ERLO ( erlotinib-resistant, delE746-A750 and MET amplification). BALB/c nude mice with subcutaneous tumor xenografts underwent two consecutive [ 11C]erlotinib PET scans, a baseline scan and a second scan in which unlabeled erlotinib (10mg/kg) was co-injected. Logan graphical analysis was used to estimate total distribution volume (VT) of [ 11C]erlotinib in tumors. RESULTS: In vitro experiments revealed significantly higher uptake of [ 11C]erlotinib (5.2-fold) in the three NSCLC cell lines as compared to A-431 cells. In all four cell lines co-incubation with unlabeled erlotinib (1μM) led to significant reductions in [ 11C]erlotinib uptake (-19% to -66%). In both PET scans and for all four studied cell lines there were no significant differences in tumoral [ 11C]erlotinib VT values. For all three NSCLC cell lines, but not for the A-431 cell line, tumoral VT was significantly reduced following co-injection of unlabeled erlotinib (-20% to -35%). CONCLUSIONS:
|
Authors | Alexander Traxl, Taraneh Beikbaghban, Thomas Wanek, Kushtrim Kryeziu, Christine Pirker, Severin Mairinger, Johann Stanek, Thomas Filip, Michael Sauberer, Claudia Kuntner, Walter Berger, Oliver Langer |
Journal | Nuclear medicine and biology
(Nucl Med Biol)
Vol. 52
Pg. 7-15
(Sep 2017)
ISSN: 1872-9614 [Electronic] United States |
PMID | 28575795
(Publication Type: Journal Article)
|
Copyright | Copyright © 2017 Elsevier Inc. All rights reserved. |
Chemical References |
- Erlotinib Hydrochloride
- EGFR protein, human
- ErbB Receptors
|
Topics |
- Animals
- Carcinoma, Non-Small-Cell Lung
(diagnostic imaging, drug therapy, metabolism, pathology)
- Cell Line, Tumor
- Cell Transformation, Neoplastic
- Drug Resistance, Neoplasm
- ErbB Receptors
(metabolism)
- Erlotinib Hydrochloride
(metabolism)
- Female
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Lung Neoplasms
(diagnostic imaging, drug therapy, metabolism, pathology)
- Mice
- Positron-Emission Tomography
|